The ECV-304 cell-line: Should it be used? [2]

European Journal of Neurology

Volumn 15, Issue 2, 2008, Pages

  Hallevi, H ^a   Hazan Hallevi, I ^b   Paran, E ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CARCINOMA; CANCER CELL CULTURE; CELL INTERACTION; CELL LINE; ECV 304 CELL LINE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LETTER; LEUKOCYTE ADHERENCE; NEUTROPHIL; PRIORITY JOURNAL;

BENZIMIDAZOLES; BRAIN ISCHEMIA; CELL ADHESION; CELL LINE; DIPYRIDAMOLE; ENDOTHELIAL CELLS; HUMANS; NEUTROPHILS; STROKE; TETRAZOLES;

EID: 38349132772     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.02029.x     Document Type: Letter

References (3)

1. Hallevi H, Hazan-Halevy I, Paran E. Modification of neutrophil adhesion to human endothelial cell line in acute ischemic stroke by dipyridamole and candesartan. Eur J Neurol 2007 14 : 1002 1007.
2. Brown J, Reading SJ, Jones S, et al. Critical evaluation of ECV-304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 2000 80 : 37 45.
3. Lidington EA, Moyes DL, McCormack AM, Rose ML. A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transpl Immunol 1999 7 : 239 246.